Figure 4. Nucleotide diversity compared between the early and late time points.
The value of each amplified fragment covering HCV genome was considered as an independent data point. Panel A, synonymous nucleotide diversity (πS). Panel B, non-synonymous nucleotide diversity (πN). Panel C, πN/πS ratio. None of the comparisons showed significant difference between the early and late time points for the categories of participants with consistent mild, mild to severe, and consistent severe disease.